top of page

返回

癌症, 推廣, 學術

[HOY TV Health Focus] Codex was recently invited to introduce our liquid biopsy test for detecting early-stage breast cancer recurrence on the HOY TV Health Focus TV show | Guardant Reveal | Cancer Liquid Biopsy

Codex recently featured on a TV show to introduce  our groundbreaking liquid biopsy test for early-stage cancer recurrence  detection. This innovative test represents a significant advancement in  cancer diagnostics, offering a non-invasive and highly accurate method  to detect cancer recurrence at its earliest stages.


Watch the full interview here: HOY TV Show Health Focus - Episode 227


Guardant Reveal is the first completely tissue-free  minimal residual disease (MRD) test, capable of accurately detecting  cancer recurrence at an early stage by analyzing circulating tumor DNA  (ctDNA) in the blood.


A heartfelt thank you to our dedicated team and everyone who has  supported us. Let’s move towards a healthier future together. 💪✨


#CancerDetection #LiquidBiopsy #Innovation #Healthcare #EarlyDetection #CancerResearch

Codex offers hereditary genetic tests for cancer and neuro diseases, and comprehensive genomic profiling for cancer treatments. The services provided by Codex Genetics are for research use only, and they are not suitable for diagnostic and/or treatment use, unless otherwise instructed by licensed medical professionals. 

科德施提供與腦神經退化和癌症基因相關的測試。 除非有醫療專業人員另行指示,此網站的服務只供研究用途,並不供作診斷或治療任何疾病之用。

  • alt.text.label.Facebook
  • alt.text.label.LinkedIn
  • alt.text.label.Instagram

Office Hours:
Monday to Friday 10:00 – 18:00
Closed on Saturdays, Sundays and public holidays.
If you need special arrangements, please contact us during office hours.

Privacy policy
​Terms of Use
Contact us

©2024 by Codex Genetics Limited

bottom of page